Table 1.
Aster flaccidus Bunge (lug-mig) and Aster diplostephioides (DC.) C.B.Clarke (a-byag-g.zer-‘joms) used in formulating three types of ETMDs.
| S. No | ETMDs | Number of ingredients | Medication form | Route of administration | Therapeutic indications in BSM [40,42] | Precautions |
|---|---|---|---|---|---|---|
| 1 | a-gar-35 a | 35 | Tablet (500 mg) | Orally, three tablets during the evening, accompanied by hot water | Dry cough, chronic fever, cardiovascular disorder, arthritis, insomnia, pain, dehydration, and other ailments, such as blood and wind related disorders (khrag-rlung) | Contains aconite. Avoid meat and alcohol while taking this medication |
| 2 | thang-chen-25 b | 25 | Capsule (400 mg) | Orally, four capsules in the morning with warm water | Stomach disorder, loss of appetite, febrifuge, and poisoning | Store in a sealed container to shield from sunlight and moisture |
| 3 | rin-chen-byur-d.mar-25 c | 25 | Pill (500 mg) | Orally, one pill in the evening with hot water after it has cooled slightly | Neurological disorder, giddiness, fainting, stiff neck, and chronic headache |
a
only Aster diplostephioide used as ingredients.
b
only Aster flaccidus used as ingredients.
c
both Aster species are used as ingredients; ETMDs – essential traditional medicine drugs; BTM – Bhutanese Sowa Rigpa medicine.